Mandragora autumnalis
Mandragora autumnalis · Accepted scientific name
Scientific literature: Very Sparse (8 studies) · ★☆☆☆☆
Mandragora autumnalis is a plant species that holds significant pharmacological potential due to its diverse therapeutic activities. Rich in beneficial chemical compounds such as flavonoids, the plant demonstrates powerful anticancer, antidiabetic, antimicrobial, and antioxidant properties. Research focuses on utilizing various plant parts, specifically the leaves and fruit, to address serious health conditions like breast cancer, heart disease, and diabetes. Various preparation methods are employed to harness these benefits, including the use of ethanolic extracts from the leaves and seeds, as well as ripe fruit preparations. Consequently, this species serves as a vital subject of study for developing natural treatments against complex metabolic and oncological diseases.
- Synonyms
- Mandragora Autumnalis Subsp. Microcarpa · Mandragora Officinarum F. Hispanica · 6 more
- Common names
- Not available
- Family
- Solanaceae
- Distribution
- Southern America
- Plant Parts
- Fruit · Leaf
Classification
Synonyms
Mandragora autumnalis is a complex botanical subject characterized by a wide array of recognized synonyms. Within various taxonomical frameworks, it has been identified as Atropa acaulis var. angustifolia and Mandragora autumnalis subsp. microcarpa. The plant's diverse classifications also include names such as Mandragora haussknechtii and Mandragora hispanica. Furthermore, researchers have historically referred to this species as Mandragora hybrida. Navigating these various nomenclatural relationships is essential for accurate identification in botanical studies.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Mandragora autumnalis belongs to the vast kingdom Plantae, representing a diverse branch of the natural world. Within this kingdom, the species is classified under the class Equisetopsida. It further falls into the order Solanales, which connects it to a specific lineage of flowering plants. As a member of the family Solanaceae, it shares botanical characteristics with many well-known nightshades. Ultimately, this plant is defined by its placement within the genus Mandragora.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Solanales |
| Family | Solanaceae |
| Genus | Mandragora |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Mandragora autumnalis exhibits a diverse geographical range that spans across both African and Asian territories. In Africa, this species is notably distributed throughout Northern Africa, with specific populations found in Algeria, Morocco, and Tunisia. Its reach extends into the Asia-Temperate zone, where it flourishes within Western Asia. Specifically, the plant can be identified in the waters surrounding Cyprus and the East Aegean Islands. This wide distribution highlights the plant's ability to adapt to various Mediterranean environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Mandragora autumnalis is characterized by its distinct growth form as a herbaceous plant.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Mandragora autumnalis is a highly significant medicinal plant recognized for its diverse range of therapeutic bioactivities. Recent research highlights its potent anticancer properties, particularly its ability to inhibit the viability and metastasis of triple-negative breast cancer cells. The plant also demonstrates strong antidiabetic effects by inhibiting key enzymes like α-amylase and α-glucosidase while promoting glucose transporter translocation. Additionally, its phytochemical composition contributes to notable antimicrobial activity against various bacterial and fungal strains. These medicinal benefits are further supported by the plant's significant antioxidant capacity, which aids in scavenging free radicals to mitigate oxidative stress.
Compounds
Mandragora autumnalis serves as a significant subject in the study of calystegine distribution within various solanaceous species. Research utilizing gas chromatography coupled to mass spectrometry has identified several specific compounds present within this plant. Specifically, the chemical profile of Mandragora autumnalis includes the presence of A3 and A5. Furthermore, the analysis confirms that the plant also contains the B-series calystegines, namely B1, B2, and B3. These findings contribute to a deeper understanding of the complex chemical makeup found in this particular species.
Conditions
Mandragora autumnalis demonstrates significant DPPH scavenging activity through its fruit flavonoid fraction. The plant's ethanolic extract effectively treats LPS-stimulated RAW 264.7 macrophages by suppressing inflammatory responses and downregulating key mediators. It also exhibits potent anti-lipase effects by inhibiting porcine pancreatic lipase. The medicinal properties of the plant extend to antidiabetic applications, specifically through the inhibition of $\alpha$-amylase and $\alpha$-glucosidase. Additionally, Mandragora autumnalis provides antimicrobial benefits by inhibiting the growth of various bacterial and fungal strains.
Preparations
Mandragora autumnalis is prepared as decoated seed to facilitate more efficient in vitro germination and seedling development for the conservation of the species. The plant is also prepared as an ethanolic extract (MAE) to investigate its potent anti-inflammatory properties and ability to stabilize proteins and cell membranes. Furthermore, Mandragora autumnalis is prepared as an ethanolic leaves extract (MAE) to evaluate its antioxidant and anticancerous activities against triple-negative breast cancer cells. Additionally, the species is prepared as ripe fruit (FFM) for the isolation of flavonoids and the study of its antidiabetic and antimicrobial effects. These various preparation methods allow researchers to explore the diverse medicinal and pharmacological potential of the plant.
Parts used
Mandragora autumnalis is a significant medicinal plant that offers various pharmacological benefits through its different biological parts. Research into the ripe fruit of the species has led to the isolation of specific flavonoids that demonstrate potent anti-diabetic and antimicrobial properties. Furthermore, the plant's leaves serve as a critical component for therapeutic studies, particularly regarding antioxidant and anticancer activities. Specifically, ethanolic extracts derived from the leaves have shown promise in suppressing the progression of triple-negative breast cancer cells. By utilizing both the fruit and the leaf, scientists continue to uncover the vast medicinal potential of this culturally important herb.